D. Ichikawa

In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist.

Y. Iwasawa, S. Ozaki, H. Ohta, 2000, European journal of pharmacology.

Identification of a novel spiropiperidine opioid receptor-like 1 antagonist class by a focused library approach featuring 3D-pharmacophore similarity.

Y. Iwasawa, S. Okuda, S. Ozaki, 2006, Journal of medicinal chemistry.

Design, synthesis, and discovery of a novel CCR1 antagonist.

A. Naya, K. Ohwaki, T. Saeki, 2001, Journal of medicinal chemistry.

A novel class of cycloalkano[b]pyridines as potent and orally active opioid receptor-like 1 antagonists with minimal binding affinity to the hERG K+ channel.

Hisashi Ohta, Hiroshi Kawamoto, Satoshi Ozaki, 2008, Journal of medicinal chemistry.

In vitro inhibitory effects of J-113397 on nociceptin/orphanin FQ-stimulated.

H. Takeshima, Y. Iwasawa, S. Ozaki, 2001, Neuroreport.